Startseite>>Isotope-Labeled Compounds>> Deuterium>>15-deoxy-δ12,14-Prostaglandin J2-d9

15-deoxy-δ12,14-Prostaglandin J2-d9 (Synonyms: 15-deoxy-Δ12,14-PGJ2-d9)

Katalog-Nr.GC46448

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

15-deoxy-δ12,14-Prostaglandin J2-d9 Chemische Struktur

Cas No.: N/A

Größe Preis Lagerbestand Menge
100 μg
494,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

15-deoxy-δ12,14-Prostaglandin J2-d9 (15-deoxy-δ12,14-PGJ2-d9) is intended for use as an internal standard for the quantification of 15-deoxy-δ12,14-PGJ2 by GC- or LC-MS. 15-deoxy-δ12,14-PGJ2 is formed from PGD2 by the elimination of two molecules of water. It binds selectively to PPARγ with an EC50 value of 2 µM in a murine chimera system.1,2 15-deoxy-δ12,14-PGJ2 is more potent than PGD2, δ12-PGJ2 , and PGJ2 in stimulating lipogenesis in C3H10T1/2 cells. The EC50 for induction of adipocyte differentiation in cultured fibroblasts is 7 µM.1

1.Kliewer, S.A., Lenhard, J.M., Willson, T.M., et al.A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiationCell83(5)813-819(1995) 2.Forman, B.M., Tontonoz, P., Chen, J., et al.15-Deoxy-δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell83(5)803-812(1995)

Bewertungen

Review for 15-deoxy-δ12,14-Prostaglandin J2-d9

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 15-deoxy-δ12,14-Prostaglandin J2-d9

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.